How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

14,023 results for

covid-19 or "novel coronavirus" or sars-Cov-2

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries Full Text available with Trip Pro

The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries The Prevalence of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries by Michael C. Grant, Luke Geoghegan, Marc Arbyn, Zakaria Mohammed, Luke McGuinness, Emily L. Clarke, Ryckie Wade :: SSRN Share: Permalink Using these links (...) of Symptoms in 24,410 Adults Infected by the Novel Coronavirus (SARS-CoV-2; COVID-19): A Systematic Review and Meta-Analysis of 148 Studies from 9 Countries 63 Pages Posted: 1 Jun 2020 University of Sheffield Imperial College London - Department of Surgery and Cancer Sciensano University of Leeds - Leeds Institute for Medical Research University of Bristol - Department of Population Health Sciences University of Leeds - Division of Pathology and Data Analytics Leeds Teaching Hospitals Trust, Department

2020 SSRN Electronic Journal

2. Efficacy and Safety Data of Treatments for Novel Coronavirus Pneumonia (SARS-Cov-2): A Systematic Review and Network Meta-Analysis of Randomized Trials Full Text available with Trip Pro

, Université Gamal Abdel Nasser de Conakry, Service de Pneumo-Phtisiologie, CHU Conakry, Hôpital National Ignace Deen de Conakry, Guinea Abstract To date, there is no definite effective treatment for the novel coronavirus (SARS-CoV-2) pandemic. To compare and rank SARS-Cov-2 treatment according to their efficacy and safety. Using the terms Covid-19 or SARS-CoV-2 and treatment , a literature search was performed from MEDLINE, GOOGLE, and CENTRAL databases until July 01, 2020. Randomized clinical trials (...) Efficacy and Safety Data of Treatments for Novel Coronavirus Pneumonia (SARS-Cov-2): A Systematic Review and Network Meta-Analysis of Randomized Trials Efficacy and Safety Data of Treatments for Novel Coronavirus Pneumonia (SARS-Cov-2): A Systematic Review and Network Meta-Analysis of Randomized Trials | | ISSN: 2474-3658 Table of Contents - - - - - - - - - - - - - - - - - - - Citation Diallo A, Traoré M, Carlos-Bolumbu M, Diallo MH, Diallo BD (2020) Efficacy and Safety Data of Treatments

2020 Journal of Infectious Diseases and Epidemiology

3. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. Full Text available with Trip Pro

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. To study the clinical characteristics of patients in Zhejiang province, China, infected with the 2019 severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) responsible for coronavirus disease 2019 (covid-2019).Retrospective case series.Seven hospitals in Zhejiang province, China.62 patients admitted to hospital with laboratory confirmed SARS (...) time from exposure to onset of illness was 4 days (interquartile range 3-5 days), and from onset of symptoms to first hospital admission was 2 (1-4) days.As of early February 2020, compared with patients initially infected with SARS-Cov-2 in Wuhan, the symptoms of patients in Zhejiang province are relatively mild.Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

2020 BMJ

4. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

to an affected area within 14 days prior to their onset of illness; or had laboratory exposure to biological material known to contain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This interim guidance is based upon Canadian guidance developed for previous coronavirus outbreaks (e.g. MERS and SARS), as well as interim guidance for COVID-19 published by the World Health Organization (WHO). It has been informed by technical advice provided by members of the Agency's National Advisory Committee (...) in close contact with a probable or confirmed case of COVID-19; or c) been in close contact with someone who has signs and symptoms of acute respiratory illness and who has travelled to an affected area within 14 days prior to their onset of illness; or d) had laboratory exposure to biological material known to contain SARS-CoV-2: Place the patient in a designated separate waiting area or space; do not cohort with other patients; Ask the patient and any accompanying individual(s) to put on a surgical

2020 CPG Infobase

5. Novel coronavirus (COVID-19) guidance for acute care

Novel coronavirus (COVID-19) guidance for acute care 1 | Pa g e Ministry of Health Novel Coronavirus (COVID-19) Guidance for Acute Care Version 2 – February 1 1, 2020 This guidance document provides basic information only. It is not intended to take the place of medical advice, communicable diseases surveillance protocols, diagnosis or treatment. What you need to know Acute care settings should: 1. Undertake active screening (asking questions) and passive screening (signage) of patients (...) to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and COVID-19. A novel coronavirus is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans, likely through bat reservoirs. Several known coronaviruses

2020 CPG Infobase

6. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness (...) caused by the novel coronavirus (COVID-19). The strategy outlined in this guidance is aligned with a containment goal (i.e. to reduce opportunities for transmission to contacts in the community) and is based on the assumption that the virus is primarily spread while the case is symptomatic. This guidance is based on current available scientific evidence and expert opinion and is subject to change as new information on the clinical spectrum, transmissibility and epidemiology becomes available

2020 CPG Infobase

7. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries Full Text available with Trip Pro

The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries ') Advertisement Publish Submissions Policies Manuscript Review and Publication Submit Your Manuscript Discover a faster, simpler path to publishing (...) in a high-quality journal. PLOS ONE promises fair, rigorous peer review, broad scope, and wide readership – a perfect fit for your research every time. About Browse Search Search Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click . Loading metrics Open Access Peer-reviewed Research Article The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review

2020 PloS one

8. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

9. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1 MED CHECK April 2020/ Vol.6 No.16 · Page C N o 16 M ED HECK 2 0 2 0 Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death 1. Don't use ibuprofen or other NSAIDs 2. Don't use corticosteroids especially in the early phase (...) of Albert Camus (November 7, 1913-January 4, 1960), a novel written in 1947, shortly after the end of World War II. It predicts the status of the current world being swept by the pandemic of the novel coronavirus infection (COVID-19). I read it for the first time when I was in the second grade of junior high school. It's been a long time, but a strange feeling after reading was completely different from other masterpieces I read in those days and has remained in my memory. The second time I read

2020 Med Check - The Informed Prescriber

10. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2

season, flu was not very prevalent due to the unusually warm winter. However, a case has been confirmed in which a medical doctor who conducted a rapid testing for a patient suspected influenza was infected with a novel coronavirus (SARS-CoV-2 or COVID-19 virus), because the patient was found infected with SARS-CV-2 later. Therefore, the Japan Medical Association recommended member doctors against testing even in case with suspected flu and recommended diagnosis based on the clinical symptoms [8 (...) injured tissues attaching ACE2 (1) SARS-CoV-2 attach ACE2 to enter the body to systemic dissemination Not only the novel coronavirus (SARS-CoV-2 or COVID-19 virus) [20-22] and SARS-CoV that emerged in 2003 [23] but also non-SARS-CoV [24] infect the human body using an enzyme called angiotensin converting enzyme-2 (ACE2). . As we have seen in the previous section, elderly people are more susceptible to COVID-19, especially those with chronic diseases. These may be deeply related. Let’s explain how

2020 Med Check - The Informed Prescriber

11. Novel Coronavirus 2019 (COVID-19)

Novel Coronavirus 2019 (COVID-19) Novel Coronavirus 2019 (COVID-19) | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Novel Coronavirus 2019 (COVID-19) Practice Advisory March 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The Centers for Disease Control and Prevention (CDC) has released and guidance for . Travel Due to the current risk of COVID-19, CDC (...) women. For more information on seasonal influenza and recommendations for pregnant women see the and . The American College of Obstetricians and Gynecologists will continue to closely monitor the evolution of the 2019 novel coronavirus (COVID-19) in collaboration with the CDC. New and updated information will be shared as it becomes available. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health

2020 American College of Obstetricians and Gynecologists

12. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)

Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Abbreviations: ABG, arterial blood gases; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus. Healthcare providers should immediately notify their local or state health department in the event of a PUI for COVID-19 and should contact and consult with their local and/or state health department for recommendations on testing PUIs for COVID-19. Outpatient (...) Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Unlike influenza and other respiratory illnesses, based on a limited number of confirmed COVID-19 cases, pregnant women do not appear to be at increased risk for severe disease. However, given the lack of data and experience with other coronaviruses such as SARS-CoV and MERS-CoV, diligence in evaluating and treating pregnant women is warranted. This algorithm is designed to aid practitioners in promptly

2020 American College of Obstetricians and Gynecologists

13. Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19)

Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) | Australian Government Department of Health Sub menu Search Menu Search Close You are here Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) guides the Australian health sector response. Listen Print Share (...) Loading... Downloads Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, . Publication date: 18 February 2020 Publication type: Strategy or framework Intended audience: General public Description: The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) includes: an overview of the national approach

2020 Queensland Health

14. NCCP guidance for Medical Professionals for testing COVID-19 in asymptomatic patients undergoing elective cancer surgery in response to the current novel coronavirus pandemic

, A., James, A., et al. (2020) Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility. The New England Journal of Medicine. DOI: 10.1056/NEJMoa2008457 ? Barbieri, L., Urquijo, E.T., Parise, P., Nilsson, M., Reynolds, J.V., Rosati, R. (2020) Esophageal oncologic surgery in SARS-CoV-2 (COVID-19) emergency. Diseases of the Esophagus. 33,1–5 ? Faculty of Radiologists (2020) COVID-19 Faculty of Radiologists guidelines 2020 Version 1.0 March 23, 2020 ? Guyatt G.H., Oxman, A.D., Kunz (...) , R., et al. (2008) Going from evidence to recommendations. BMJ, 336:1049–1051. doi: 10.1136/bmj.39493.646875.AE. ? HIQA (2020) Rapid health technology assessment of alternative diagnostic testing approaches for the detection of severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2). 17 April 2020, Dublin, Ireland. ? Intercollegiate Guidance (2020). Guidelines for pre-operative COVID-19 testing for elective cancer surgery (13th May 2020). https://www.rcsed.ac.uk/media/681195/guidelines

2020 Health Service Executive (Ireland) - Clinical Guidelines

15. Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic

Lung cancer: NCCP advice for medical professionals on the management of patients undergoing Lung Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic Version: 1 Department: NCCP Radiation Oncology Working Group Update date: 05/06/2020 Code: RO_COVID19_12 1 NCCP advice for medical professionals on the management of patients undergoing lung cancer radiotherapy in response to the current novel coronavirus COVID 19 pandemic This document relates to patients who do (...) not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID-19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges that each hospital is working under individual constraints, including

2020 Health Service Executive (Ireland) - Clinical Guidelines

16. NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak

NCCP advice for Medical Professionals on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) outbreak 1 NCCP advice for Medical Professionals on the management of patients undergoing SACT Changes and additions from the last version are highlighted in yellow Version: 12.0 Department: NCCP Update date: 15/06/2020 CD19-013-003 Revision date: NCCP Systemic Therapy Programme NCCP advice for Medical Professionals (...) on the management of patients undergoing Systemic Anti-Cancer Therapy (chemotherapy) in response to the current novel coronavirus (COVID-19) pandemic 1 Overview Current events surrounding the COVID 19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary

2020 Health Service Executive (Ireland) - Clinical Guidelines

17. Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic

Thyroid cancer: NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic Version: 1 Department: NCCP Radiation Oncology Working Group Update date: 22/04/2020 Code: RO_COVID19_6 Page 1 of 3 NCCP advice for medical professionals on the management of Thyroid Cancer and Overactive Thyroid Disease in response to the current novel coronavirus (COVID-19) pandemic This document relates (...) to patients who do not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID 19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges that each hospital is working under individual constraints

2020 Health Service Executive (Ireland) - Clinical Guidelines

18. Prostate cancer: NCCP advice for Medical Professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak

Prostate cancer: NCCP advice for Medical Professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Version: 2 Department: NCCP Radiation Oncology Working Group Update date: 30/06/2020 Code: RO_COVID19_7 Page 1 of 3 NCCP advice for medical professionals on the management of patients undergoing Prostate Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) pandemic This document (...) relates to patients who do not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID 19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges that each hospital is working under individual

2020 Health Service Executive (Ireland) - Clinical Guidelines

19. Breast cancer: NCCP guidance for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak

Breast cancer: NCCP guidance for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Version: 1 Department: NCCP Radiation Oncology Working Group Last updated: 01/04/2020 Code: RO_COVID19_1 Date for revision: 15/04/2020 Page 1 of 3 NCCP advice for Medical Professionals on the management of patients undergoing Breast Cancer Radiotherapy in response to the current novel coronavirus (COVID-19 (...) ) outbreak This document relates to patients who do not have COVID-19 or are not suspected of having COVID-19. Current events surrounding the COVID 19 pandemic are challenging and all public health bodies are placing the safety of patients, staff and communities first in all decisions. This is an evolving situation. This advice is based on current information, it is additional to the advice of the NPHET, the HSE and the DoH, and will be updated as necessary. The NCCP acknowledges that each hospital

2020 Health Service Executive (Ireland) - Clinical Guidelines

20. NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) outbreak

NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) outbreak Version: 2 Department: NCCP Radiation Oncology Working Group Last updated: 22/04/2020 Code: RO_COVID19_2 Page 1 of 4 NCCP guidance on the use of PPE by medical professionals when managing patients requiring radiotherapy in response to the current novel coronavirus (COVID-19) pandemic Current events surrounding the COVID 19 (...) circumstances. The purpose of this advice is to maximise the safety of patients and make the best use of HSE resources, while protecting staff from infection. It will also enable services to match the capacity for cancer care to patient needs if services become limited due to the COVID-19 pandemic. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 1 NPHET

2020 Health Service Executive (Ireland) - Clinical Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>